Abstract:Allergic rhinitis (AR) is a common allergic disease with a complex pathogenesis involving various genetic factors, protein regulation, and environmental influences. In recent years, the widespread application of omics technologies, such as genomics, transcriptomics, proteomics, and metabolomics, has greatly advanced our understanding of the pathogenesis of AR. This review summarizes the latest progress of various omics technologies in AR research, where genomic studies have revealed multiple risk gene loci associated with AR, and transcriptomic analyses have emphasized the role of differentially expressed genes and their regulatory networks in AR. Additionally, proteomics and metabolomics research has provided significant support for the identification of novel biomarkers and potential therapeutic targets. This article also discusses the potential of multi-omics integrative analysis in the precision medicine of AR, suggesting that future research should focus on data integration and application transformation to further advance the diagnosis and treatment of AR.